IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Intercept Pharmaceuticals in

CUSIP: 45845PAB4 | 64 institutional holders

Quarters

Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2023

UBS Asset Management Americas LLC3,000,000
0.0% of portfolio›$3.0M
StyleTurnoverLocationFiled
UBS Asset Management Americas LLC
3,000,000$3.0M0.0%GrowthLowNew York, NY2024-02-14